> top > docs > PMC:1189074 > spans > 17032-17578 > annotations

PMC:1189074 / 17032-17578 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T4058 491-493 IN denotes of
T4057 482-490 NN denotes activity
T4056 478-481 DT denotes the
T4055 463-467 MD denotes must
T4054 448-451 CD denotes two
T4053 452-462 NNS denotes substrates
T4052 442-447 DT denotes these
T4051 437-441 IN denotes with
T4050 428-436 VBN denotes measured
T4049 405-418 NN denotes dehydrogenase
T4048 396-404 JJ denotes residual
T4047 419-427 NN denotes activity
T4046 392-395 DT denotes the
T4045 390-392 , denotes ,
T4044 384-385 SYM denotes −
T4043 383-384 HYPH denotes /
T4042 382-383 SYM denotes −
T4041 386-390 NNS denotes mice
T4040 378-382 NN denotes MCAD
T4039 375-377 IN denotes in
T4038 366-374 VBN denotes detected
T4037 353-357 NN denotes MCAD
T4036 358-365 NN denotes antigen
T4035 350-352 DT denotes no
T4034 342-349 RB denotes clearly
T4033 468-477 VB denotes represent
T4032 332-337 EX denotes there
T4031 338-341 VBD denotes was
T4030 324-331 IN denotes Because
T4029 323-546 sentence denotes Because there was clearly no MCAD antigen detected in MCAD−/− mice, the residual dehydrogenase activity measured with these two substrates must represent the activity of other chain length–specific acyl-CoA dehydrogenases.
T4028 322-323 . denotes .
T4027 321-322 -RRB- denotes )
T4026 320-321 CD denotes 0
T4025 319-320 : denotes :
T4024 316-319 NN denotes C16
T4023 315-316 -LRB- denotes (
T4022 310-311 HYPH denotes -
T4021 311-314 NN denotes CoA
T4020 301-310 NN denotes palmitoyl
T4019 296-300 IN denotes with
T4018 293-295 RB denotes so
T4017 288-292 RBR denotes less
T4016 284-287 VBD denotes was
T4015 279-283 DT denotes This
T4014 278-323 sentence denotes This was less so with palmitoyl-CoA (C16:0).
T4013 277-278 . denotes .
T4012 272-273 HYPH denotes -
T4011 273-276 NN denotes CoA
T4010 270-272 NN denotes C8
T4009 265-269 IN denotes with
T4008 260-264 CD denotes zero
T4007 255-259 IN denotes near
T4006 252-254 IN denotes to
T4005 241-243 VBZ denotes is
T4004 232-240 NN denotes activity
T4003 227-231 NN denotes MCAD
T4002 244-251 VBN denotes reduced
T4001 221-226 WRB denotes where
T4000 212-220 NNS denotes patients
T3999 206-211 JJ denotes human
T3998 203-205 IN denotes in
T3997 198-202 NN denotes case
T3996 194-197 DT denotes the
T3995 191-193 VBZ denotes is
T3994 188-190 IN denotes as
T3993 186-188 , denotes ,
T3992 182-183 HYPH denotes -
T3991 183-186 NN denotes CoA
T3990 180-182 NN denotes C8
T3989 166-179 VB denotes dehydrogenate
T3988 163-165 TO denotes to
T3987 147-154 VBN denotes reduced
T3986 133-146 RB denotes significantly
T3985 155-162 NN denotes ability
T3984 131-132 DT denotes a
T3983 127-130 VBD denotes had
T3982 120-121 SYM denotes −
T3981 119-120 HYPH denotes /
T3980 118-119 SYM denotes −
T3979 122-126 NNS denotes mice
T3978 114-118 NN denotes MCAD
T3977 113-278 sentence denotes MCAD−/− mice had a significantly reduced ability to dehydrogenate C8-CoA, as is the case in human patients where MCAD activity is reduced to near zero with C8-CoA .
T3976 112-113 . denotes .
T3975 97-106 JJ denotes enzymatic
T3974 107-112 NN denotes level
T3973 93-96 DT denotes the
T3972 90-92 IN denotes at
T3971 83-84 SYM denotes −
T3970 82-83 HYPH denotes /
T3969 81-82 SYM denotes −
T3968 77-81 NN denotes MCAD
T3967 85-89 NNS denotes mice
T3966 73-76 DT denotes the
T3965 60-72 VB denotes characterize
T3964 57-59 TO denotes to
T3963 42-46 VBD denotes were
T3962 30-41 NNS denotes homogenates
T3961 24-29 NN denotes liver
T3960 21-23 IN denotes of
T3959 47-56 VBN denotes performed
T3958 4-13 NN denotes reduction
T3957 14-20 NNS denotes assays
T3956 0-3 NN denotes ETF
T4068 545-546 . denotes .
T4067 526-527 HYPH denotes -
T4066 527-530 NN denotes CoA
T4065 522-526 NN denotes acyl
T4064 512-513 HYPH denotes –
T4063 513-521 JJ denotes specific
T4062 506-512 NN denotes length
T4061 500-505 NN denotes chain
T4060 531-545 NNS denotes dehydrogenases
T4059 494-499 JJ denotes other
R2459 T3956 T3957 compound ETF,assays
R2460 T3957 T3959 nsubjpass assays,performed
R2461 T3958 T3957 compound reduction,assays
R2462 T3960 T3957 prep of,assays
R2463 T3961 T3962 compound liver,homogenates
R2464 T3962 T3960 pobj homogenates,of
R2465 T3963 T3959 auxpass were,performed
R2466 T3964 T3965 aux to,characterize
R2467 T3965 T3959 advcl characterize,performed
R2468 T3966 T3967 det the,mice
R2469 T3967 T3965 dobj mice,characterize
R2470 T3968 T3967 nmod MCAD,mice
R2471 T3969 T3968 punct −,MCAD
R2472 T3970 T3968 punct /,MCAD
R2473 T3971 T3968 punct −,MCAD
R2474 T3972 T3965 prep at,characterize
R2475 T3973 T3974 det the,level
R2476 T3974 T3972 pobj level,at
R2477 T3975 T3974 amod enzymatic,level
R2478 T3976 T3959 punct .,performed
R2479 T3978 T3979 nmod MCAD,mice
R2480 T3979 T3983 nsubj mice,had
R2481 T3980 T3978 punct −,MCAD
R2482 T3981 T3978 punct /,MCAD
R2483 T3982 T3978 punct −,MCAD
R2484 T3984 T3985 det a,ability
R2485 T3985 T3983 dobj ability,had
R2486 T3986 T3987 advmod significantly,reduced
R2487 T3987 T3985 amod reduced,ability
R2488 T3988 T3989 aux to,dehydrogenate
R2489 T3989 T3985 acl dehydrogenate,ability
R2490 T3990 T3991 compound C8,CoA
R2491 T3991 T3989 dobj CoA,dehydrogenate
R2492 T3992 T3991 punct -,CoA
R2493 T3993 T3983 punct ", ",had
R2494 T3994 T3995 mark as,is
R2495 T3995 T3983 advcl is,had
R2496 T3996 T3997 det the,case
R2497 T3997 T3995 attr case,is
R2498 T3998 T3995 prep in,is
R2499 T3999 T4000 amod human,patients
R2500 T4000 T3998 pobj patients,in
R2501 T4001 T4002 advmod where,reduced
R2502 T4002 T4000 relcl reduced,patients
R2503 T4003 T4004 compound MCAD,activity
R2504 T4004 T4002 nsubjpass activity,reduced
R2505 T4005 T4002 auxpass is,reduced
R2506 T4006 T4002 prep to,reduced
R2507 T4007 T4008 quantmod near,zero
R2508 T4008 T4006 pobj zero,to
R2509 T4009 T4002 prep with,reduced
R2510 T4010 T4011 compound C8,CoA
R2511 T4011 T4009 pobj CoA,with
R2512 T4012 T4011 punct -,CoA
R2513 T4013 T3983 punct .,had
R2514 T4015 T4016 nsubj This,was
R2515 T4017 T4018 advmod less,so
R2516 T4018 T4016 advmod so,was
R2517 T4019 T4016 prep with,was
R2518 T4020 T4021 compound palmitoyl,CoA
R2519 T4021 T4019 pobj CoA,with
R2520 T4022 T4021 punct -,CoA
R2521 T4023 T4024 punct (,C16
R2522 T4024 T4016 parataxis C16,was
R2523 T4025 T4024 punct :,C16
R2524 T4026 T4024 nummod 0,C16
R2525 T4027 T4024 punct ),C16
R2526 T4028 T4016 punct .,was
R2527 T4030 T4031 mark Because,was
R2528 T4031 T4033 advcl was,represent
R2529 T4032 T4031 expl there,was
R2530 T4034 T4031 advmod clearly,was
R2531 T4035 T4036 det no,antigen
R2532 T4036 T4031 attr antigen,was
R2533 T4037 T4036 compound MCAD,antigen
R2534 T4038 T4036 acl detected,antigen
R2535 T4039 T4038 prep in,detected
R2536 T4040 T4041 nmod MCAD,mice
R2537 T4041 T4039 pobj mice,in
R2538 T4042 T4040 punct −,MCAD
R2539 T4043 T4040 punct /,MCAD
R2540 T4044 T4040 punct −,MCAD
R2541 T4045 T4033 punct ", ",represent
R2542 T4046 T4047 det the,activity
R2543 T4047 T4033 nsubj activity,represent
R2544 T4048 T4047 amod residual,activity
R2545 T4049 T4047 compound dehydrogenase,activity
R2546 T4050 T4047 acl measured,activity
R2547 T4051 T4050 prep with,measured
R2548 T4052 T4053 det these,substrates
R2549 T4053 T4051 pobj substrates,with
R2550 T4054 T4053 nummod two,substrates
R2551 T4055 T4033 aux must,represent
R2552 T4056 T4057 det the,activity
R2553 T4057 T4033 dobj activity,represent
R2554 T4058 T4057 prep of,activity
R2555 T4059 T4060 amod other,dehydrogenases
R2556 T4060 T4058 pobj dehydrogenases,of
R2557 T4061 T4062 compound chain,length
R2558 T4062 T4063 npadvmod length,specific
R2559 T4063 T4060 amod specific,dehydrogenases
R2560 T4064 T4063 punct –,specific
R2561 T4065 T4066 compound acyl,CoA
R2562 T4066 T4060 compound CoA,dehydrogenases
R2563 T4067 T4066 punct -,CoA
R2564 T4068 T4033 punct .,represent

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T4680 522-530 CHEBI:17984 denotes acyl-CoA
T4679 386-390 NCBITaxon:10088 denotes mice
T4678 358-365 CHEBI:59132 denotes antigen
T4677 301-314 CHEBI:15525 denotes palmitoyl-CoA
T4676 273-276 CHEBI:15346 denotes CoA
T4675 206-211 NCBITaxon:9606 denotes human
T4674 183-186 CHEBI:15346 denotes CoA
T4673 166-179 MOP:0000590 denotes dehydrogenate
T4672 122-126 NCBITaxon:10088 denotes mice
T4671 85-89 NCBITaxon:10088 denotes mice
T4670 24-29 UBERON:0002107 denotes liver
T4669 4-13 MOP:0000569 denotes reduction
T4668 0-3 GO:0045251 denotes ETF

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T4794 522-545 GO_EXT:0003995 denotes acyl-CoA dehydrogenases
T4793 522-530 CHEBI:17984 denotes acyl-CoA
T4792 386-390 NCBITaxon:10088 denotes mice
T4791 384-385 SO_EXT:sequence_nullness_or_absence denotes −
T4790 382-383 SO_EXT:sequence_nullness_or_absence denotes −
T4789 378-382 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T4788 358-365 CHEBI_EXT:59132 denotes antigen
T4787 353-357 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T4786 301-314 CHEBI:15525 denotes palmitoyl-CoA
T4785 273-276 CHEBI:15346 denotes CoA
T4784 227-231 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T4783 206-211 NCBITaxon:9606 denotes human
T4782 183-186 CHEBI:15346 denotes CoA
T4781 166-179 MOP:0000590 denotes dehydrogenate
T4780 122-126 NCBITaxon:10088 denotes mice
T4779 120-121 SO_EXT:sequence_nullness_or_absence denotes −
T4778 118-119 SO_EXT:sequence_nullness_or_absence denotes −
T4777 114-118 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T4776 97-106 CHEBI_GO_SO_EXT:enzyme denotes enzymatic
T4775 85-89 NCBITaxon:10088 denotes mice
T4774 83-84 SO_EXT:sequence_nullness_or_absence denotes −
T4773 81-82 SO_EXT:sequence_nullness_or_absence denotes −
T4772 77-81 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T4771 24-29 UBERON:0002107 denotes liver
T4770 4-13 MOP:0000569 denotes reduction
T4769 0-3 GO:0045251 denotes ETF